---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-058120"
form_type: "8-K/A"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2026-08-20T01:42:34+00:00"
generated_at: "2026-08-20T10:05:31.051851+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Skye Bioscience reverse stock split effective Aug 24, 2026; ticker stays SKYE

## Summary
- Reverse stock split becomes effective at 12:01 am New York time on August 24, 2026.
- Common stock begins trading split-adjusted on Nasdaq at market open August 24, 2026, under ticker SKYE.
- New CUSIP for post-split common stock is 83086J309.
- Amendment confirms effective date of previously disclosed reverse split; no change to ticker symbol.

## SEC filing metadata
- accession: 0001628280-26-058120
- form_type: 8-K/A
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2026-08-20T01:42:34+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000162828026058120/0001628280-26-058120-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000162828026058120/skye-20260812.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-058120
- JSON: https://secwatch.observer/filing/0001628280-26-058120.json
- Plain text: https://secwatch.observer/filing/0001628280-26-058120.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.